GSK takes £3bn hit after US setback for potential cancer blockbuster
- Posted on July 18, 2025
- By The Times
- 2 Views
GSK takes £3bn hit after US setback for potential cancer blockbuster
US approval for blood cancer drug Blenrep is up in the air after an advisory committee warned risks could outweigh benefits
